Growth Metrics

Tango Therapeutics (TNGX) Assets Average (2020 - 2025)

Historic Assets Average for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $224.0 million.

  • Tango Therapeutics' Assets Average fell 3895.01% to $224.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.0 million, marking a year-over-year decrease of 3895.01%. This contributed to the annual value of $359.5 million for FY2024, which is 1429.95% down from last year.
  • Tango Therapeutics' Assets Average amounted to $224.0 million in Q3 2025, which was down 3895.01% from $256.1 million recorded in Q2 2025.
  • Tango Therapeutics' 5-year Assets Average high stood at $515.1 million for Q4 2021, and its period low was $167.9 million during Q2 2021.
  • In the last 5 years, Tango Therapeutics' Assets Average had a median value of $393.8 million in 2024 and averaged $367.3 million.
  • As far as peak fluctuations go, Tango Therapeutics' Assets Average skyrocketed by 17427.96% in 2021, and later crashed by 3895.01% in 2025.
  • Over the past 5 years, Tango Therapeutics' Assets Average (Quarter) stood at $515.1 million in 2021, then fell by 12.59% to $450.3 million in 2022, then fell by 7.76% to $415.4 million in 2023, then decreased by 19.48% to $334.5 million in 2024, then crashed by 33.02% to $224.0 million in 2025.
  • Its last three reported values are $224.0 million in Q3 2025, $256.1 million for Q2 2025, and $295.4 million during Q1 2025.